Back to Top
Top Nav Content Site Footer
University Home
College of Engineering & Science

Alumnus appointed CEO of Open Therapeutics

May 18, 2016

Jerome Hamilton, ’97 Master of Science in Engineering Management, was as appointed CEO of Open Therapeutics LLC on May 13.

Jerome HamiltonHamilton will lead Open Therapeutics’ scale and global expansion, as well as manage business development, sales, marketing, and investor relations.

Hamilton joins Open Therapeutics after serving as Stratasys’ Senior Vice President of Global Operations, before which he was Vice President of LEAN Six Sigma Operations, Corporate Quality and Acquisition Integration for 3M. There, he played a major role in devising strategy and operational plans for the company’s largest business group, Industrial Business Group. He also led the company’s Masking and Surface Protection Business with full P&L responsibility.

“With the Open Therapeutics’ unique model, we will break down the pharma silos of non-disclosure that limit collaboration amongst scientists,” says Hamilton.

Hamilton is a member of the Boards of Directors of Goodwill Easter Seals Minnesota, Real Life 101, and V2SOFT. He was listed in the 2014 Savoy Magazine list of Most Influential Blacks in Corporate America and was recognized as one of the Top 50 diversity professionals in industry– Global Diversity List, supported by The Economist, (

Read the press release.

Back to Top